FDA Allows Caraco to Resume Some Operations at Two Michigan Facilities

Washington Drug Letter
A A
Sun Pharmaceuticals’ Caraco unit may resume some of its Detroit and Wixom, Mich., operations after recent FDA inspections show it is in compliance with a 2009 consent decree.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00